2004 Annual Meeting | Clinical Application of Novel Angiographic Techniques in Cerebrovascular Disease

��ɫ��

2004 Annual Meeting | Clinical Application of Novel Angiographic Techniques in Cerebrovascular Disease

Date Monday 04/26/04

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) David S. Liebeskind, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should be able to comprehend the current status of novel angiographic techniques; describe the clinical application of these imaging modalities; and understand the advantages and disadvantages of each imaging approach.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse, Other

Event Timeline
06:45 PM - 07:15 PM		Overview of Current CTA, MRA, and DSA Techniques David S. Liebeskind, MD, FAAN
07:15 PM - 07:45 PM		Neuroimaging Correlates of Cerebrovascular Anatomy Hamza I. Maqsood, MD
07:45 PM - 08:15 PM		Clinical Applications From Source Images to 3D David S. Liebeskind, MD, FAAN
08:15 PM - 08:45 PM		Multimodal Angiographic Comparisons - Advantages and Disadvantages Hamza I. Maqsood, MD
08:45 PM - 09:10 PM		Case Examples
09:10 PM - 09:30 PM		Questions and Answers Hamza I. Maqsood, MD, David S. Liebeskind, MD, FAAN

Faculty Disclosures
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.

��ɫ����

��ɫ����

��ɫ��

��ɫ��